Vericel (VCEL) Other Non Operating Income (2010 - 2026)
Vericel's (VCEL) quarterly Other Non Operating Income came in at $71000.0 in Q1 2026, up 69.05% year-on-year from $42000.0 in Q1 2025, and up 297.22% quarter-over-quarter from -$36000.0 in Q4 2025.
Vericel (VCEL) Other Non Operating Income (2010 - 2026) Analysis & Trends
Vericel has disclosed Other Non Operating Income across 17 years of filings, most recently posting $71000.0 for Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $71000.0, up 69.05% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15000.0 (down 106.15% YoY), and the FY2025 annual result was -$44000.0, down 122.56% from the prior year.
- Other Non Operating Income came in at $71000.0 for Q1 2026 at Vericel, up from -$36000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $140000.0 in Q3 2024 to a low of -$36000.0 in Q4 2025.
- The 5-year median for Other Non Operating Income is -$5000.0 (2022), against an average of $22411.8.
- Across the five-year window, Other Non Operating Income surged 14100.0% in 2024 and plunged 200.0% in 2025, its largest moves.
- Vericel's Other Non Operating Income stood at -$3000.0 in 2022, then jumped by 2833.33% to $82000.0 in 2023, then slipped by 14.63% to $70000.0 in 2024, then slumped by 151.43% to -$36000.0 in 2025, then jumped by 297.22% to $71000.0 in 2026.
- The last three Other Non Operating Income figures came in at $71000.0 (Q1 2026), -$36000.0 (Q4 2025), and -$26000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71,000.00 |
| Dec 31, 2025 | -36,000.00 |
| Sep 30, 2025 | -26,000.00 |
| Jun 30, 2025 | -24,000.00 |
| Mar 31, 2025 | 42,000.00 |
| Dec 31, 2024 | 70,000.00 |
| Sep 30, 2024 | 140,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | 82,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -5,000.00 |
| Mar 31, 2023 | -12,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | -5,000.00 |
| Jun 30, 2022 | -9,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | -13,000.00 |
| Jun 30, 2021 | -27,000.00 |